| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/06/2013 | CN102917730A Modified meningococcal fHBP polypeptides |
| 02/06/2013 | CN102917729A Immunogenic proteins and compositions |
| 02/06/2013 | CN102917717A Anti-tumor composition |
| 02/06/2013 | CN102917713A Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | CN102917690A Lipid vesicle compositions and methods of use |
| 02/06/2013 | CN102917689A Novel process |
| 02/06/2013 | CN102917688A Novel process |
| 02/06/2013 | CN102914658A Application of CRISP3 protein on diagnosis and treatment of prostate cancer |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911910A Human embryo lung fibroblast strain and method for using human embryo lung fibroblast strain for producing hand-foot-mouth viral vaccine |
| 02/06/2013 | CN102911285A Process for refining group C/Y/W135 meningococcal polysaccharides |
| 02/06/2013 | CN102908625A Chicken Newcastle disease and avian infectious bronchitis bivalent live vaccine heat-resistant protective agent and preparation process thereof |
| 02/06/2013 | CN102908620A Preparation method of egg yolk antibody injection for treating piglet diarrhea |
| 02/06/2013 | CN102908619A Preparation method of egg yolk antibody injection for treating porcine respiratory syndrome |
| 02/06/2013 | CN102908618A Preparation method of divalent inactivated vaccines for duck virus hepatitis |
| 02/06/2013 | CN102908617A Porcine reproductive and respiratory syndrome virus M protein and CD40L fusion vaccine and preparation method |
| 02/06/2013 | CN102908616A Riemerella anatipestifer tervalent inactivated vaccine and preparation method thereof |
| 02/06/2013 | CN102908615A Novel haemophilus parasuis disease trivalent inactivated vaccine and preparation method thereof |
| 02/06/2013 | CN102908613A Porcine immuno-enhancer IL-12B (P40) and preparation method thereof |
| 02/06/2013 | CN102908368A Preparation method of virus lyophilized preparation |
| 02/06/2013 | CN102295684B Insulin chain A human leukocyte antigen (HLA)-A*0201 restrictive cytotoxic T lymphocyte (CTL) epitope altered peptide ligand and application thereof |
| 02/06/2013 | CN102188703B Usage of yeast in preparation of anticoccidial drugs |
| 02/06/2013 | CN102178941B Novel helicobacter pylori multiepitope vaccine and preparation method thereof |
| 02/06/2013 | CN101966335B Novel HER2/neu gene-modified dendritic cell vaccine |
| 02/06/2013 | CN101870733B Poultry IL-2 and newcastle disease virus HN gene recombination fusion protein and application thereof |
| 02/06/2013 | CN101816783B Recombinant Mycobacterium smegmatis vaccine expressing HBHA-IL-12 fusion protein |
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101553728B The use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC) |
| 02/06/2013 | CN101395176B Peptide sequences and compositions |
| 02/06/2013 | CN101378778B Vaccine comprising streptococcus pneumoniae capsular polyaccharide conjugates |
| 02/05/2013 | US8367808 Methods, devices, kits and compositions for detecting whipworm |
| 02/05/2013 | US8367806 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 02/05/2013 | US8367805 Fc variants with altered binding to FcRn |
| 02/05/2013 | US8367643 Antiinflammatory agents; prevent infections |
| 02/05/2013 | US8367384 Bone semi-permeable device |
| 02/05/2013 | US8367319 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 02/05/2013 | US8367317 Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof |
| 02/05/2013 | US8367315 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 02/05/2013 | US8367076 Glyceroglycolipid antigen of Mycoplasma pneumoniae |
| 02/05/2013 | US8367075 Synergistic combination and method thereof |
| 02/05/2013 | US8367074 Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 02/05/2013 | US8367073 Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof |
| 02/05/2013 | US8367071 Stimulant of immunology response |
| 02/05/2013 | US8367070 Modified surface antigen |
| 02/05/2013 | US8367069 Cytotoxic T cell defined EGFR peptide and an optimized derivative peptide |
| 02/05/2013 | US8367068 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/05/2013 | US8367067 Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 02/05/2013 | US8367066 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 02/05/2013 | US8367065 Targeted polymeric prodrugs containing multifunctional linkers |
| 02/05/2013 | US8367063 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 02/05/2013 | US8367062 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 02/05/2013 | US8367061 Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs) |
| 02/05/2013 | US8367055 Immunogenic compositions against tuberculosis |
| 02/05/2013 | US8367052 Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 02/05/2013 | CA2676188C Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 02/05/2013 | CA2504867C Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 02/05/2013 | CA2472265C Immunogenic formulations of variable peptidic epitopes and process for preparation thereof |
| 02/05/2013 | CA2468935C Adjuvanted antigenic meningococcal compositions |
| 02/05/2013 | CA2440221C Expression technology for proteins containing a hybrid isotype antibody moiety |
| 02/05/2013 | CA2429636C Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 02/05/2013 | CA2352454C Peptide-based vaccine for influenza |
| 02/05/2013 | CA2340091C Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 01/31/2013 | WO2013016675A1 Dendritic cell (dc)-vaccine therapy for pancreatic cancer |
| 01/31/2013 | WO2013016648A2 Stabilized formulations containing anti-pcsk9 antibodies |
| 01/31/2013 | WO2013016634A1 Use of il-12 to generate endogenous erythropoietin |
| 01/31/2013 | WO2013016468A2 Compositions and methods for improving potency and breadth or hiv antibodies |
| 01/31/2013 | WO2013016465A1 Target of the phosphoinositide 3-kinase pathway |
| 01/31/2013 | WO2013016220A1 Il-17 receptor a is required for il-17c biology |
| 01/31/2013 | WO2013015831A1 Methods and compositions for vaccinating against staphylococcus aureus |
| 01/31/2013 | WO2013015821A1 Antibodies to the b12-transcobalamin receptor |
| 01/31/2013 | WO2013015744A1 Mixed lineage leukemia 5 isoform is a potential biomarker and therapeutic target for hpv-associated cervical cancer |
| 01/31/2013 | WO2013015586A2 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 01/31/2013 | WO2013014668A1 Variants of humanized immunomodulatory monoclonal antibodies |
| 01/31/2013 | WO2013014405A2 Methods |
| 01/31/2013 | WO2013014273A1 Novel salmonella bacteriophage compositions and uses thereof |
| 01/31/2013 | WO2013014261A1 Prevention of salmonella recrudescense |
| 01/31/2013 | WO2013014255A1 Exosome inhibiting agents and uses thereof |
| 01/31/2013 | WO2013014247A1 Use of epitopes inducing specific tolerance for the prevention of tissue rejection |
| 01/31/2013 | WO2013014128A1 Compositions having means for targeting at least one antigen to dendritic cells |
| 01/31/2013 | WO2013014105A1 Prame purification |
| 01/31/2013 | WO2013013323A1 Staphlococcus aureus alpha-hemolysin antibodies |
| 01/31/2013 | WO2013013302A1 Synthetic lethality and the treatment of cancer |
| 01/31/2013 | WO2012170513A3 He4 based therapy for malignant disease |
| 01/31/2013 | WO2012170125A3 Algal produced malarial transmission blocking vaccines |
| 01/31/2013 | WO2012149412A3 Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof |
| 01/31/2013 | WO2012149301A3 Tolerogenic synthetic nanocarriers for inducing regulatory b cells |
| 01/31/2013 | WO2012140627A4 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer |
| 01/31/2013 | WO2012138754A3 Mycobacterial vaccine vectors and methods of using the same |
| 01/31/2013 | WO2012135812A3 Treatment for dermatological pathologies |
| 01/31/2013 | WO2012116210A3 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus |
| 01/31/2013 | WO2012006341A8 Anti-ron antibodies |
| 01/31/2013 | WO2011159871A8 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 01/31/2013 | US20130031647 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 01/31/2013 | US20130030030 Allantoin-containing skin cream |
| 01/31/2013 | US20130028978 Compositions and methods for wound treatment |
| 01/31/2013 | US20130028961 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
| 01/31/2013 | US20130028959 Liposomes for Preventing the Spread of HIV |